Aarti Pharmalabs Limited has announced significant changes in its directorate, approved by shareholders at its 7th Annual General Meeting (AGM) held on September 22, 2026. Shri Rajendra Gogri ceased to be a director, Smt. Hetal Gogri Gala was re-designated from Managing Director to Whole-time Director, and Shri Rashesh C. Gogri has been appointed as the new Managing Director, all effective from October 1, 2026.
Key Directorate Changes Approved
At the 7th Annual General Meeting (AGM) of Aarti Pharmalabs Limited, held on September 22, 2026, shareholders approved important changes to the company’s directorate. These changes, effective from October 1, 2026, aim to refine the leadership structure and strategic oversight of the company.
Directorate Updates
Following the AGM proceedings and based on the voting results, Shri Rajendra Gogri (DIN: 00061003), who was eligible for retirement by rotation, has ceased to be a Director of the Company. He did not offer himself for re-appointment.
In a strategic re-alignment of roles, Smt. Hetal Gogri Gala (DIN: 00005499) has been re-designated from her position as Managing Director to that of a Whole-time Director. This change allows for a focused allocation of responsibilities within the executive management.
Furthermore, the company has appointed Shri Rashesh C. Gogri (DIN: 00066291) as the new Managing Director. His designation has been changed from Non-Executive Director to Managing Director, marking a significant step in his leadership role within Aarti Pharmalabs.
Disclosure Information
The detailed disclosures pertaining to these changes in directorate are provided in Annexure-A, in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information is also accessible on the company’s official website.
Source: BSE
